The effect of intestinal colonization of germ-free pigs with Escherichia coli on calprotectin levels in plasma, intestinal and bronchoalveolar lavages

Immunobiology

Volumn 209, Issue 9, 2005, Pages 681-687

  Šplíchal, Igor ^a   Fagerhol, Magne K ^b   Trebichavský, Ilja ^a   Šplíchalová, Alla ^a   Schulze, Jürgen ^c  

^a INSTITUTE OF MICROBIOLOGY   (Czech Republic)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^c Ardeypharm GmbH   (Germany)

Author keywords

Calprotectin; Inflammatory bowel disease; Probiotics

Indexed keywords

CALPROTECTIN; MUTAFLOR; PROBIOTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; CONTROLLED STUDY; ENTERITIS; ENTEROBACTER INFECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FROZEN SECTION; GERMFREE ANIMAL; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; INTESTINE LAVAGE; LUNG LAVAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEPTICEMIA; SMALL INTESTINE; STATISTICAL SIGNIFICANCE; SWINE;

EID: 14244266340     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imbio.2004.09.009     Document Type: Article

References (44)

1. A. Altenhoefer S. Oswald U. Sonnenborn C. Enders J. Schulze J. Hacker T.A. Oelschlaeger The probiotic Escherichia coli strain Nissle 1917 interferes with invasion of human intestinal epithelial cells by different enteroinvasive bacterial pathogens FEMS Immunol. Med. Microbiol. 40 2004 223-229
2. I. Bjarnason R. Sherwood Fecal calprotectin: A significant step in the noninvasive assessment of intestinal inflammation J. Pediatr. Gastroenterol. Nutr. 33 2001 11-13
3. G. Blum R. Marre J. Hacker Properties of Escherichia coli strains of serotype O6 Infection 23 1995 234-236
4. G. Blum-Oehler S. Oswald K. Eiteljorge U. Sonnenborn J. Schulze W. Kruis J. Hacker Development of strain-specific PCR reactions for the detection of the probiotic Escherichia coli strain Nissle 1917 in fecal samples Res. Microbiol. 154 2003 59-66
5. J. Boudeau A.L. Glasser S. Julien J.F. Colombel A. Darfeuille-Michaud Inhibitory effect of probiotic Escherichia coli strain Nissle 1917 on adhesion to and invasion of intestinal epithelial cells by adherent-invasive E.coli strains isolated from patients with Crohn's disease Aliment. Pharmacol. Ther. 18 2003 45-56
6. E. Bruckschen H. Horosiewicz Chronische Obstipation, Verglich von mikrobiologischer Therapie und Lactulose Münch. Med. Wochenschr. 16 1994 241-245
7. B. Cukrowska H. Kozakova Z. Rehakova J. Sinkora H. Tlaskalova-Hogenova Specific antibody and immunoglobulin responses after intestinal colonization of germ-free piglets with non-pathogenic Escherichia coli O86 Immunobiology 204 2001 425-433
8. B. Cukrowska R. Lodinova-Zadnikova C. Enders U. Sonnenborn J. Schulze H. Tlaskalova-Hogenova Specific proliferative and antibody responses of premature infants to intestinal colonization with nonpathogenic probiotic E. coli strain Nissle 1917 Scand. J. Immunol. 55 2002 204-209
9. I. Dale M.K. Fagerhol I. Naesgaard Purification and partial characterization of a highly immunogenic human leukocyte protein, the L1 antigen Eur. J. Biochem 134 1983 1-6
10. M.K. Fagerhol Calprotectin, a faecal marker of organic gastrointestinal abnormality Lancet 356 2000 1783-1784
11. R.J. Fitzhenry S. Reece L.R. Trabulsi R. Heuschkel S. Murch M. Thomson G. Frankel A.D. Phillips Tissue tropism of enteropathogenic Escherichia coli strains belonging to the O55 serogroup Infect. Immun. 70 2002 4362-4368
12. M.H. Floch Probiotics, irritable bowel syndrome, and inflammatory bowel disease Curr. Treat. Options Gastroenterol. 6 2003 283-288
13. P. Fric M. Zavoral The effect of non-pathogenic Escherichia coli in symptomatic uncomplicated diverticular disease of the colon Eur. J. Gastroenterol. Hepatol. 15 2003 313-315
14. L. Grozdanov U. Zahringer G. Blum-Oehler L. Brade A. Henne Y.A. Knirel U. Schombel J. Schulze U. Sonnenborn G. Gottschalk J. Hacker E.T. Rietschel U. Dobrindt A single nucleotide exchange in the wzy gene is responsible for the semirough O6 lipopolysaccharide phenotype and serum sensitivity of Escherichia coli strain Nissle 1917 J. Bacteriol. 184 2002 5912-5925
15. R.M. Hoffmann Medikametöse Therapie in Orientierung an der Klinik: Colitis ulcerosa In: J.C. Hoffmann A.J. Kroesen B. Klump (Eds.) Chronisch entzündliche Darmenkrankungen 2004 Georg Thieme Verlag Stuttgart New York pp 1-158
16. B. Johne M.K. Fagerhol T. Lyberg H. Prydz P. Brandtzaeg C.F. Naess-Andresen I. Dale Functional and clinical aspects of the myelomonocyte protein calprotectin Mol. Pathol. 50 1997 113-123
17. J. Kido R. Kido Suryono M. Kataoka M.K. Fagerhol T. Nagata Calprotectin release from human neutrophils is induced by Porphyromonas gingivalis lipopolysaccharide via the CD14-Toll-like receptor-nuclear factor kappaB pathway J. Periodontal Res. 38 2003 557-563
18. W. Kruis P. Fric J. Pokrotnieks M. Lukas B. Fixa M. Kascak M.A. Kamm J. Weimueller C. Beglinger M. Stolte C. Wolff J. Schulze Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine Gut 53 2004 1617-1623
19. W. Kruis E. Schutz P. Fric B. Fixa G. Judmaier M. Stolte Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis Aliment. Pharmacol. Ther. 11 1997 853-858
20. L. Kuzela M. Kascak A. Vavrecka Induction and maintenance of remission with nonpathogenic Escherichia coli in patients with pouchitis Am. J. Gastroenterol. 96 2001 3218-3219
21. N. Laforgia M.E. Baldassarre G. Pontrelli F. Indrio M.A. Altomare B.G. Di A. Mautone Calprotectin levels in meconium Acta Paediatr. 92 2003 463-466
22. R. Lodinova-Zadnikova U. Sonnenborn Effect of preventive administration of a nonpathogenic Escherichia coli strain on the colonization of the intestine with microbial pathogens in newborn infants Biol. Neonate 71 1997 224-232
23. R. Lodinova-Zadnikova U. Sonnenborn H. Tlaskalova Probiotics and E. coli infections in man Vet. Q. 20 Suppl 3 1998 S78-S81
24. H.A. Malchow Crohn's disease and Escherichia coli A new approach in therapy to maintain remission of colonic Crohn's disease? J. Clin. Gastroenterol. 25 1997 653-658
25. L. Mandel Rearing of germ-free piglets In: 0I. Lefkovits (Ed.) Immunology Methods Manual 2004 Academic Press New York 1-1544
26. M. Mollenbrink E. Bruckschen [Treatment of chronic constipation with physiologic Escherichia coli bacteria. Results of a clinical study of the effectiveness and tolerance of microbiological therapy with the E. coli Nissle 1917 strain (Mutaflor)] Med. Klin. (Munich) 89 1994 587-593
27. K. Nisapakultorn K.F. Ross M.C. Herzberg Calprotectin expression inhibits bacterial binding to mucosal epithelial cells Infect. Immun. 69 2001 3692-3696
28. A. Nissle Die antagonistische Behandlung chronischer Darmstorungen mit Colibacterien Med. Klinik. 2 1918 29-30
29. S.I. Patzer M.R. Baquero D. Bravo F. Moreno K. Hantke The colicin G, H and X determinants encode microcins M and H47, which might utilize the catecholate siderophore receptors FepA, Cir, Fiu and IroN Microbiology 149 2003 2557-2570
30. A. Poullis R. Foster M.A. Mendall M.K. Fagerhol Emerging role of calprotectin in gastroenterology J. Gastroenterol. Hepatol. 18 2003 756-762
31. B.J. Rembacken A.M. Snelling P.M. Hawkey D.M. Chalmers A.T. Axon Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: A randomised trial Lancet 354 1999 635-639
32. A.G. Roseth Determination of faecal calprotectin, a novel marker of organic gastrointestinal disorders Dig. Liver Dis. 35 2003 607-609
33. A.G. Roseth M.K. Fagerhol E. Aadland H. Schjonsby Assessment of the neutrophil dominating protein calprotectin in feces. A methodologic study Scand. J. Gastroenterol. 27 1992 793-798
34. J. Rugtveit M.K. Fagerhol Age-dependent variations in fecal calprotectin concentrations in children J. Pediatr. Gastroenterol. Nutr. 34 2002 323-324
35. D.C. Savage Microbial ecology of the gastrointestinal tract Annu. Rev. Microbiol. 31 1977 107-133
36. J. Schulze A. Lorenz L. Mandel Colonization of Escherichia coli in different gnotobiotic animal models Microb. Ecol. Health Dis. 5 1992 4-5
37. E. Schutz The treatment of intestinal diseases with Mutaflor. A multicenter retrospective study Fortschr. Med. 107 1989 599-602
38. U. Sonnenborn R. Greinwald Beziehungen zwischen Wirtsorganismus und Darmflora (Antagonismus von E. coli gegen undere Mikroorganisme) 1991 Verlag Schattauer Stuttgart, New York pp. 1-55
39. I. Splichal I. Trebichavsky Y. Muneta Y. Mori Early cytokine response of gnotobiotic piglets to Salmonella enterica serotype typhimurium Vet. Res. 33 2002a 291-297
40. I. Splichal I. Trebichavsky A. Splichalova L. Ditetova M. Zahradnickova Escherichia coli administered into pig amniotic cavity appear in fetal airways and attract macrophages into fetal lungs Physiol. Res. 51 2002b 523-528
41. I. Striz I. Trebichavsky Calprotectin-a pleiotropic molecule in acute and chronic inflammation Physiol. Res. 53 2004 245-253
42. H. Tlaskalova-Hogenova V. Kamarytova L. Mandel L. Prokesova J. Kruml A. Lanc I. Miler The immune response of germ-free piglets after peroral monocontamination with living Escherichia coli strain O86 Fol. Biol. 16 1970 177-187
43. A. Tromm U. Niewerth M. Khoury E. Baestlein G. Wilhelms J. Schulze M. Stolte The probiotic E. coli strain Nissle 1917 for the treatment of collagenous colitis: First results of an open-label trial Z. Gastroenterol. 42 2004 365-369
44. J. Wehkamp J. Harder B. Wehkamp-von Meissner L. Schwichtenberg K. Fellermann K.R. Herrlinger M. Schroeder E.F. Stange The probiotic E. coli Nissle 1917 (Mutaflor®) induces defensins in intestinal epithelial cells: A novel mechanism of action Gastroenterology 122 Suppl. 1 2002 A75-635